{"id":19759,"date":"2024-11-23T18:15:18","date_gmt":"2024-11-23T17:15:18","guid":{"rendered":"https:\/\/inmuno.es\/index.php\/2024\/11\/23\/enhancing-tumor-immunity-via-in-vivo-cdc1-reprogramming-yoojung-kwon\/"},"modified":"2024-11-23T18:15:18","modified_gmt":"2024-11-23T17:15:18","slug":"enhancing-tumor-immunity-via-in-vivo-cdc1-reprogramming-yoojung-kwon","status":"publish","type":"post","link":"https:\/\/inmuno.es\/index.php\/2024\/11\/23\/enhancing-tumor-immunity-via-in-vivo-cdc1-reprogramming-yoojung-kwon\/","title":{"rendered":"Enhancing tumor immunity via in vivo cDC1 reprogramming. Yoojung Kwon"},"content":{"rendered":"<div>\n<p>Trends Immunol. 2024 Nov 21:S1471-4906(24)00279-5. doi: 10.1016\/j.it.2024.11.008. Online ahead of print.<\/p>\n<p>ABSTRACT<\/p>\n<p>A recent study by Ascic et al. demonstrates that in situ reprogramming of tumor cells into conventional dendritic cell (cDC)-like cells using viral-PIB transcription factors creates an immunogenic tumor microenvironment with T cell recruitment and activation. The study highlights the potential of tumor-specific cancer immunotherapy using in vivo reprogrammed cDCs.<\/p>\n<p>PMID:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39578119\/?utm_source=WordPress&amp;utm_medium=rss&amp;utm_content=100966032&amp;ff=20241123121518&amp;v=2.18.0.post9+e462414\">39578119<\/a> | DOI:<a href=\"https:\/\/doi.org\/10.1016\/j.it.2024.11.008\">10.1016\/j.it.2024.11.008<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Trends Immunol. 2024 Nov 21:S1471-4906(24)00279-5. doi: 10.1016\/j.it.2024.11.008. Online ahead of print. ABSTRACT A recent study by Ascic et al. demonstrates that in situ reprogramming of tumor cells into conventional dendritic cell (cDC)-like cells using viral-PIB transcription factors creates an immunogenic tumor microenvironment with T cell recruitment and activation. The study highlights the potential of tumor-specific &#8230; <a title=\"Enhancing tumor immunity via in vivo cDC1 reprogramming. Yoojung Kwon\" class=\"read-more\" href=\"https:\/\/inmuno.es\/index.php\/2024\/11\/23\/enhancing-tumor-immunity-via-in-vivo-cdc1-reprogramming-yoojung-kwon\/\" aria-label=\"Read more about Enhancing tumor immunity via in vivo cDC1 reprogramming. Yoojung Kwon\">Read more<\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,68],"tags":[],"class_list":["post-19759","post","type-post","status-publish","format-standard","hentry","category-publicaciones","category-trends-in-immunology"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/19759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=19759"}],"version-history":[{"count":0,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/19759\/revisions"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=19759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/categories?post=19759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/tags?post=19759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}